Neurotez,Inc. (Equity)

Funding Details
Awarder
StartEngine
Date Award
March 11, 2022
Vertical
Biotechnology
Funding URL
View Funding Page
Valuation
$44,870,000

Company Info
Traction
None
Organizations Involved
None
Founders
Nikolaos Tezapsidis, Bob Oliver, Thomas Humphries
Company Description
Neurotez Inc. is developing a Leptin product as a hormone replacement therapy for Alzheimers disease.
Market
Healthcare
Location
Bridgewater, NJ, US
Coinvestors
None

Links
Back to Home Back to Biotechnology Deals View Funding Announcement